deferoxamine has been researched along with ciclopirox in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, Z; You, Q; Zhang, X | 1 |
| Davidoff, AM; Rankovic, Z; Wang, Y; Wu, Q; Yang, J; Young, B | 1 |
| Farinelli, SE; Greene, LA | 1 |
| Eckhardt, K; Katschinski, DM; Linden, T; Pagel, H; Scheid, A; Wenger, RH | 1 |
| Luciano, JA; Scholz, PM; Tan, T; Weiss, HR | 1 |
| Adler, I; Arend, M; Flippin, LA; Manaenko, A; Milosevic, J; Schwarz, J; Schwarz, SC; Storch, A; Walkinshaw, G | 1 |
| Al-awar, R; Alizadeh, S; Aman, A; Attisano, L; Bao, RY; Chau, A; Christova, T; Gronda, M; Hogge, DE; Hurren, R; Isaac, M; Jitkova, Y; Joseph, B; Kasper, J; Miller, BW; Perusini, S; Schimmer, AD; Song, S; Subramaniam, R; Weir, SJ; Wrana, JL | 1 |
2 review(s) available for deferoxamine and ciclopirox
| Article | Year |
|---|---|
Medicinal chemistry of metal chelating fragments in metalloenzyme active sites: A perspective.
Topics: Animals; Catalytic Domain; Chelating Agents; Chemistry, Pharmaceutical; Drug Design; Humans; Metalloproteins | 2019 |
Recent Advances with KDM4 Inhibitors and Potential Applications.
Topics: Enzyme Inhibitors; Histone Demethylases; Humans; Jumonji Domain-Containing Histone Demethylases; Neoplasms | 2022 |
1 trial(s) available for deferoxamine and ciclopirox
| Article | Year |
|---|---|
Wnt inhibitor screen reveals iron dependence of β-catenin signaling in cancers.
Topics: Acute Disease; Administration, Oral; Benzoates; beta Catenin; Cell Line, Tumor; Cell Proliferation; Ciclopirox; Colorectal Neoplasms; Deferasirox; Deferoxamine; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; HEK293 Cells; Humans; Hydrazones; Iron; Iron Chelating Agents; Leukemia, Myeloid; Oligonucleotide Array Sequence Analysis; Promoter Regions, Genetic; Pyridones; Reverse Transcriptase Polymerase Chain Reaction; Triazoles; Wnt Proteins; Wnt Signaling Pathway | 2011 |
4 other study(ies) available for deferoxamine and ciclopirox
| Article | Year |
|---|---|
Cell cycle blockers mimosine, ciclopirox, and deferoxamine prevent the death of PC12 cells and postmitotic sympathetic neurons after removal of trophic support.
Topics: Animals; Aphidicolin; Apoptosis; Cell Cycle; Cell Division; Ciclopirox; Cyclic AMP; Deferoxamine; G1 Phase; Mimosine; Mitosis; Nerve Growth Factors; Neurons; Nocodazole; PC12 Cells; Pyridones; Rats; Superior Cervical Ganglion; Teniposide; Thionucleotides | 1996 |
The antimycotic ciclopirox olamine induces HIF-1alpha stability, VEGF expression, and angiogenesis.
Topics: 2,2'-Dipyridyl; Allantois; Animals; Antifungal Agents; Binding Sites; Binding, Competitive; Chick Embryo; CHO Cells; Chorion; Ciclopirox; Cricetinae; Deferoxamine; Endothelial Growth Factors; Gene Expression Regulation; Hypoxia-Inducible Factor 1, alpha Subunit; In Vitro Techniques; Intercellular Signaling Peptides and Proteins; Iron; Kidney; Luciferases; Lymphokines; Mice; Neovascularization, Physiologic; Pyridones; Rabbits; Rats; Recombinant Fusion Proteins; Skin; Transcription Factors; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2003 |
Hypoxia inducible factor-1 improves the actions of positive inotropic agents in stunned cardiac myocytes.
Topics: Animals; Antifungal Agents; Calcium Signaling; Cardiotonic Agents; Ciclopirox; Colforsin; Deferoxamine; Dose-Response Relationship, Drug; Hypoxia-Inducible Factor 1, alpha Subunit; Iron Chelating Agents; Myocardial Contraction; Myocardial Stunning; Myocytes, Cardiac; Ouabain; Pyridones; Rabbits; Reperfusion Injury; Time Factors; Up-Regulation | 2009 |
Non-hypoxic stabilization of hypoxia-inducible factor alpha (HIF-alpha): relevance in neural progenitor/stem cells.
Topics: Actins; Analysis of Variance; Antifungal Agents; Cell Cycle; Cell Death; Cell Differentiation; Cell Line, Transformed; Cell Proliferation; Cell Survival; Ciclopirox; Cobalt; Deferoxamine; Dose-Response Relationship, Drug; Embryonic Stem Cells; Fetus; Humans; Hyperbaric Oxygenation; Hypoxia-Inducible Factor 1, alpha Subunit; Mesencephalon; Nerve Tissue Proteins; Pyridones; Siderophores | 2009 |